SECURITIES AND EXCHANGE COMMISSION
8 December 2016
ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Sangamo BioSciences, Inc.
File No. 0-30171 -- CF# 34340
_____________________
Sangamo BioSciences, Inc. submitted an application under Rule 24b-2 requesting
confidential treatment for information it excluded from the Exhibits to a Form 10-Q filed
on October 27, 2016.
Based on representations by Sangamo BioSciences, Inc. that this information
qualifies as confidential commercial or financial information under the Freedom of
Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined
not to publicly disclose it. Accordingly, excluded information from the following
exhibit(s) will not be released to the public for the time period(s) specified:
Exhibit 10.1 through January 8, 2019
Exhibit 10.2 through July 10, 2022
Exhibit 10.3 through September 20, 2026
For the Commission, by the Division of Corporation Finance, pursuant to
delegated authority:
Brent J. Fields
Secretary
NEW YORK (GenomeWeb News) – Dow AgroSciences has struck a collaboration with Australia's Victoria Department of Primary Industries (DPI)to develop new genetics technologies to boost crop performance, the Dow Chemical subsidiary said this week.
Under the agreement, the partners plan to develop elite crop varieties with improved productivity and product quality traits.
The collaboration expands an earlier research and development program, launched in 2009, between DPI and Dow AgroSciences, a subsidiary of Dow Chemical.
Today:
Dec. 7, 2016
Source: Dow AgroSciences news release
New and innovative forage products are on the horizon driven by continued collaboration between Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), and Agriculture Victoria, Australia.
Dow AgroSciences works on a variety of projects with Agriculture Victoria through its commercial arm, Agriculture Victoria Services Pty Ltd. (AVS), and today announces that AVS is taking a commercial license to the EXZACT™ Precision Technology Platform to continue the development and commercialization of new forage grass varieties to benefit farmers in Australia and around the world.
The commercial license agreement focuses on the development of forage grass varieties and associated fungal endophytes developed using precision genome editing technologies. It builds on the major Research License Agreement AVS has with Dow AgroSciences to conduct research using the company's proprietary EXZACT™ Technology.
The announcement of a milestone commercial license between Dow AgroSciences and AVS recognizes the advances Agriculture Victoria has made researching and developing innovative forage products using this gene editing platform that Dow AgroSciences has developed under an exclusive license and collaboration agreement in plants with Sangamo BioSciences, Inc.
"Our focus is on the farmer, and this commercial license validates the broad application of the EXZACT™ technology that can translate into new products for farmers around the world, and also illustrates the power of collaboration to advance technology," said Daniel R. Kittle, Ph.D., vice president, Research and Development, Dow AgroSciences.
"Our most productive collaboration with Dow AgroSciences has enabled the development of a suite of innovations for crop improvement. It has also provided us with access to the EXZACT™ technology for its application in forage grasses with global reach, to deliver benefits on-farm to dairy, beef and sheep industries," said Professor German Spangenberg, Agriculture Victoria's Executive Director Biosciences Research.
Under the agreement, the partners plan to develop elite crop varieties with improved productivity and product quality traits.
The collaboration expands an earlier research and development program, launched in 2009, between DPI and Dow AgroSciences, a subsidiary of Dow Chemical.
Today:
Dec. 7, 2016
Source: Dow AgroSciences news release
New and innovative forage products are on the horizon driven by continued collaboration between Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), and Agriculture Victoria, Australia.
Dow AgroSciences works on a variety of projects with Agriculture Victoria through its commercial arm, Agriculture Victoria Services Pty Ltd. (AVS), and today announces that AVS is taking a commercial license to the EXZACT™ Precision Technology Platform to continue the development and commercialization of new forage grass varieties to benefit farmers in Australia and around the world.
The commercial license agreement focuses on the development of forage grass varieties and associated fungal endophytes developed using precision genome editing technologies. It builds on the major Research License Agreement AVS has with Dow AgroSciences to conduct research using the company's proprietary EXZACT™ Technology.
The announcement of a milestone commercial license between Dow AgroSciences and AVS recognizes the advances Agriculture Victoria has made researching and developing innovative forage products using this gene editing platform that Dow AgroSciences has developed under an exclusive license and collaboration agreement in plants with Sangamo BioSciences, Inc.
"Our focus is on the farmer, and this commercial license validates the broad application of the EXZACT™ technology that can translate into new products for farmers around the world, and also illustrates the power of collaboration to advance technology," said Daniel R. Kittle, Ph.D., vice president, Research and Development, Dow AgroSciences.
"Our most productive collaboration with Dow AgroSciences has enabled the development of a suite of innovations for crop improvement. It has also provided us with access to the EXZACT™ technology for its application in forage grasses with global reach, to deliver benefits on-farm to dairy, beef and sheep industries," said Professor German Spangenberg, Agriculture Victoria's Executive Director Biosciences Research.